SUMMARY Eleven male patients with genital warts were given injections of fibroblast interferon (300 u) and placebo into the bases of two similar warts. The changes in size of the treated warts compared with that of the controls suggested that interferon did inhibit the growth of the warts. The dose given was probably insufficient for a dramatic effect. In one patient, however, a wart on the penile shaft was injected with interferon and did disappear within two weeks whereas an untreated meatal wart increased in size.
Introduction
Genital warts (condylomata accuminata) are a common sexually transmissible benign viral infection (Oriel and Almeida, 1970; Oriel, 1971) . Treatment is usually with chemical or physical agents and is designed to remove the warty tissue. Infected cells tend to be left behind and the tumour commonly grows again. In a preliminary open study followed by a double-blind study comparing human leucocyte interferon ointment with placebo, interferon was effective in eliminating genital warts in most women treated (Ikic et al., 1975a, b) .
This study was designed to see if a single minimal dose of human fibroblast interferon (HFIF) injected into the base of a small genital wart would have any effect on its growth.
Patients and methods
Twelve male patients (age range 18-32) were admitted to the study. Details of the patients and their warts are shown in Table 1 . All except one patient had warts on the penile shaft; the other had fleshy warts in the groin. All except one patient had two small warts of a similar size and appearance; one had a single wart on the shaft and a meatal wart (Patient 4).
Four patients had had warts for six months or longer and repeated applications of podophyllin had failed to remove them completely. Three others had had previous episodes of warts which had been Received for publication 30 November 1978 temporarily removed by podophyllin or electrocautery; the warts had recurred when treatment was stopped. Three patients experiencing their first attack had received no treatment whereas the other six had had podophyllin treatment which so far had not affected the warts. The most recent podophyllin application took place more than one month before treatment with interferon. Most patients had soft fleshy warts but one (Patient 7) had planar warts resembling verucca vulgaris.
The local ethical committee gave approval for the study; all patients were made conversant with the aims of the experiment and were assured that the treatment would not cure the warts. They then gave their written consent to the experiment.
After the injections the patients were instructed to attend weekly for three weeks. Only seven of the 12 patients complied exactly with the instructions but all except one were seen and assessed at the second or third week after interferon treatment. PREPARATION Sehgal et al. (1976) . Interferon activity was measured by assessing the dilution which caused a 50% reduction in the cytopathic effect of Sindbis virus on Vero cells. Assay of the material at the end of the trial to break the code showed that solution A contained 3000 u/ml of interferon in two separate samples. 442 Effect ofinjections ofsmall doses ofhumanfibroblast interferon into genital warts The control solution used was a mock fibroblast interferon derived from an abortive induction process and contained no antiviral activity in the above assay. The cell-line interferon and mock interferon were subjected to stringent tests to ensure the absence of adventitious agents. Previous studies using intradermal injections of high titre fibroblast interferon (Scott et al. 1977 (Scott et al. , 1978 had shown no toxic effects except for painless local redness occurring four hours after injection and lasting for 24 hours.
INJECTION OF WARTS
Each volunteer received a single injection of 0-1 ml solution A (300 u interferon) into the base of one wart (group A warts) and 0-1 ml solution B (mock interferon) into another wart of similar size and appearance (group B warts). The materials were packed in single-dose syringes and the investigator was unaware which was the active and which the control solution. (Patient 4, who had one wart on the penile shaft and meatal wart, received an injection of solution A and the meatal wart was left as control.) All the warts not injected with either solution were left as controls (group C). All the warts were measured using dividers transferred to a mm scale, and the maximum and minimum diameters (mm) were recorded on the first day and then weekly for a maximum of three weeks. 
REACTIONS
All patients reported that the injections caused intense local stinging for 5-10 seconds, but one patient volunteered that the stinging of the injections was less intense than the pain induced by electrocautery. There were mild erythematous reactions at the injection sites at 24 hours and no systemic symptoms.
Results
The area of the wart was calculated from the maximum (d max) and minimum (d min) diameters assuming they were elliptical; i(d max/2) (d min/2) Excluding patient 4, the mean size of warts was 10-0 mm2 (range 2-4-20) in group A, I113 mm2 (4 7-30) in group B, and 36-0 mm2 (5 f9-165) in the uninjected warts (group C). Changes in the size of warts are shown graphically in Figure 1 logarithm of the change in size of the warts between the first (pretreatment) and last (at one, two, or three weeks) attendance at the clinic before alternative treatment was instituted (Table 2) . Patient 4, treated only with solution A, was excluded from the analysis. Patient 7 was assessed at one week; between the first and third weeks he was inadvertently treated with podophyllin.
The geometric mean of the ratio of the follow-up size to initial size was 0-92 (group A), 1 19 (group B), and 1*33 (group C). The overall difference between the three groups was not statistically significant. Between group A and groups B plus C, however, the difference was of borderline significance (P=0 045, two-tailed test). Thus warts treated with solution A (interferon) grew significantly less than all the other warts including those treated with mock interferon (solution B) and the untreated controls. There was no difference in the response to interferon in patients previously treated with podophyllin.
In the case of patient 4, a single wart on the penile shaft was treated with solution A (interferon) alone, and by the second week after injection the wart had disappeared leaving a faint scar. Meanwhile the untreated meatal wart had considerably increased in size.
Discussion
This pilot study indicates that the injection of a small dose of interferon may influence the growth of genital warts compared with that of controls. In one patient the wart injected with interferon disappeared within two weeks. Unfortunately there was no similar wart treated with mock interferon, so the disappearance could have occurred by chance, even though the untreated meatal wart increased in size. Ikic et al. (1975a, b) studied the effect of relatively impure human leucoccyte interferon in an ointment ///--/base (4000 u/g) rubbed into vulval and vaginal warts five times a day. In an open study (Ikic et al., 1975a) 
